USO DE UM ANTAGONISTA DE INTERLEUCINA 1 (IL-1), MÉTODO PARA TRATAR, INIBIR, OU MELHORAR PSEUDOGOTA, USO DE UM OU MAIS AGENTES TERAPÊUTICOS, E, PRODUTO.

摘要

Methods of treating, inhibiting, or ameliorating gout, including chronic acute (refractory) gout or pseudogout in a human subject in need thereof, comprising administering to a subject in need a therapeutic amount of an interleukin 1 (IL-1) antagonist, wherein gout or pseudogout are inhibited or ameliorated. Preferably, the IL-1 antagonist is the protein of SEQ ID NO:10 (rilonacept).